Description
Taficita 200 mg/25 mg Tablets – Advanced HIV Management
Taficita 200 mg/25 mg Tablets are a combination antiretroviral medication containing 200 mg Emtricitabine and 25 mg Tenofovir Alafenamide (TAF), manufactured by Mylan Pharmaceuticals. These tablets are designed to manage HIV-1 infection in adults and adolescents aged 12 years and older, weighing at least 35 kg, in combination with other antiretroviral agents.
Key Features:
- Active Ingredients: 200 mg Emtricitabine and 25 mg Tenofovir Alafenamide
- Dosage Form: Film-coated tablet
- Indication: Treatment of HIV-1 infection in combination with other antiretroviral agents
- Administration: Swallow whole; do not chew, crush, or split
- Food Interaction: Can be taken with or without food
- Storage: Store in a cool, dry place away from sunlight and moisture
How Taficita Works
Taficita combines two nucleoside reverse transcriptase inhibitors (NRTIs): Emtricitabine and Tenofovir Alafenamide. These medications work by inhibiting the reverse transcriptase enzyme, which is essential for the replication of HIV. By suppressing viral replication, Taficita helps to reduce the amount of HIV in the blood, thereby improving immune function and reducing the risk of progression to AIDS.
Recommended Usage
- Dosage: One tablet daily
- Timing: Take at the same time each day
- Administration: Swallow the tablet whole with a glass of water; do not chew, crush, or split
- Food: Can be taken with or without food
Side Effects
Common side effects may include:
- Headache
- Diarrhea
- Nausea
- Fatigue
- Dizziness
Serious side effects are rare but may include:
- Severe allergic reactions
- Kidney problems
- Bone density loss
If you experience any serious side effects, seek immediate medical attention.
Drug Interactions
Taficita may interact with certain medications, including:
- Rifamycins (e.g., Rifampin)
- Phenytoin
- Carbamazepine
- St. John’s Wort
Inform your healthcare provider about all medications you are taking to avoid potential interactions.
Precautions
- Not recommended for: Children under 12 years of age or weighing less than 35 kg
- Use with caution in: Individuals with liver or kidney problems, or a history of bone issues
- Pregnancy and breastfeeding: Consult your doctor before use
Why Choose Taficita?
Taficita offers a convenient once-daily dosing regimen, making it easier to adhere to your HIV treatment plan. Its combination of Emtricitabine and Tenofovir Alafenamide provides effective suppression of HIV replication, helping to maintain a strong immune system and reduce the risk of HIV-related complications.
